JPRN-UMIN000023879Completed未知
Validation study of the recurrence risk stratification using 55-gene classifier (55GC) and RAS mutation in StageII/III colon cancer - Validation study of the recurrence risk stratification using 55-gene classifier (55GC) and RAS mutation in StageII/III colon cancer
ational Defense Medical College and Kyushu University0 sites1,000 target enrollmentStarted: September 1, 2016Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 1,000
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to 79years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1) Patients who had received preoperative therapy. (2) Patients with a previous malignancy, within 5 years of operation, except for tumors at the stage of carcinoma in situ. (3) Patients who had recurrence or died within 60 days of surgery.
Investigators
Similar Trials
Recruiting
Not Applicable
Blunt chest trauma risk stratification score validation studytraumaThoracic complicationsEmergency medicine - Other emergency careACTRN12619000160134Saptarshi Mukerji500
Recruiting
Phase 2
Evaluating the recurrence rate and adverse events of transversalis muscle fascia repair in total extraperitoneal repair (TEP) of inguinal herniaInguinal herniaIRCT20180312039067N2Esfahan University of Medical Sciences60
Completed
Not Applicable
A prospective study to predict the risk for recurrence of advanced rectal cancer based on combined analysis of MRI and ctDNAJPRN-UMIN000042588Sapporo Medical University Hospital30
Completed
Phase 4
Exploratory study to evaluate the recurrence prediction factor in patients with completely resected colorectal cancer which has adjuvant therapy of XELOX.(KPUM-DS-C03)Colorectal CancerJPRN-UMIN000011459Kyoto Prefectural University of Medicine Department of Surgery Division of Digestive Surgery251
Not yet recruiting
Not Applicable
A prospective study for the assessment of recurrence risk in stage II colon cancer patients using ColoPrint.adenocarcinoma of the colon10017990colon cancerNL-OMON31942Agendia B.V.100